[Vasodilators in heart failure? Basic principles and its role in practice].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D014665:Vasodilator Agents; D006830:Hydralazine; D008914:Minoxidil; D005665:Furosemide; D002216:Captopril; D003981:Diazoxide; D011224:Prazosin; D010646:Phentolamine
Vasodilatatoren bei der Herzinsuffizienz? Grundlagen und Standortbestimmung für die Praxis.